Cargando…
Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries
Background: Rising expenditure for new cancer medicines is accelerating concerns that their costs will become unsustainable for universal healthcare access. Moreover, early market access of new oncology medicines lacking appropriate clinical evaluation generates uncertainty over their cost-effective...
Autores principales: | Pisana, Alice, Wettermark, Björn, Kurdi, Amanj, Tubic, Biljana, Pontes, Caridad, Zara, Corinne, Van Ganse, Eric, Petrova, Guenka, Mardare, Ileana, Fürst, Jurij, Roig-Izquierdo, Marta, Melien, Oyvind, Bonanno, Patricia Vella, Banzi, Rita, Marković-Peković, Vanda, Mitkova, Zornitsa, Godman, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295616/ https://www.ncbi.nlm.nih.gov/pubmed/35865969 http://dx.doi.org/10.3389/fphar.2022.873556 |
Ejemplares similares
-
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
por: Godman, Brian, et al.
Publicado: (2021) -
Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”
por: Godman, Brian, et al.
Publicado: (2023) -
Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
por: Bojanić, Ljubica, et al.
Publicado: (2018) -
Availability and accessibility of monoclonal antibodies in Bosnia and
Herzegovina: Findings and implications
por: Tubic, Biljana, et al.
Publicado: (2021) -
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
por: Godman, Brian, et al.
Publicado: (2018)